Mindray Ultrasound 迈瑞医疗

China · Shenzhen

alternative to GE HealthCare / Philips / Siemens Healthineers

Resona and Consona cart-based ultrasound systems, TE-series point-of-care scanners, the TE Air wireless handheld and Hepatus liver-assessment units, used in radiology, cardiology, obstetrics and emergency care.

Why it fits

  • Medical Imaging
  • Global-ready

Regional alternatives

Product facts

Segment
Medical Imaging
Role
Manufacturer

Mindray says it ranked #1 in China's ultrasound market by 2025 revenue (H1 2026 interim results, Aug 2026).

Market authorizations

United States

  • FDA 510(k) cleared: Resona A20 series diagnostic ultrasound systems
    K253049 · decided 2026-02-11 Source (checked 2026-10)
  • FDA 510(k) cleared: Consona N5 / N3 series diagnostic ultrasound systems
    K251853 · decided 2025-11-07 Source (checked 2026-10)

European Union

  • CE marked (MDR): Resona I10 diagnostic ultrasound system (Class IIa)
    69449040AB0501004869 Source (checked 2026-10)

Verified records only; absence here does not mean a product is unauthorized.

Regulatory & supply-chain notes

EU · procurement ban
Tenders from Chinese suppliers are excluded from EU public procurement of medical devices (CPV 331) worth €5 million or more, until 30 June 2030; winning bidders may source at most 50% of the contract value from China. An EU-based subsidiary with real business in the EU may bid, but its China-made devices count toward that 50%. Smaller tenders and private buyers are not affected.
International Procurement Instrument · Medical devices from China in EU public tenders of €5 million or more · effective 2025-06-30 · source ↗

Company & market

Parent company
Shenzhen Mindray Bio-Medical Electronics
Registered
Shenzhen
Listing
A-share
Ticker
300760.SZ
Market cap / val. (USD)
~$30 B
Foreign-investable
No